Several studies have demonstrated that specific hormone receptors (HR) such as progesterone receptor (PGR), growth hormone receptor (GHR), and follicle-stimulating hormone receptor (FSHR) were present in vascular tumors and vascular malformations [5, 7, 14]. This evidence concerns the gene NR4A1 and vascular malformation.